Overall rank by patents
#41,639
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01K (Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals).
The verdict
According to USPTO PatentsView, Megabass ranks #41,639 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 1 technology areas.
USPTO PatentsView assignee plate
Corpus R41639 · Foreign Corporation #41,639 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Medrelief Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Megabass · this assignee
16 score
3D Lighting… · lowest
7 score
What this shows Megabass's Innovation Score is 15.8/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Megabass, Inc is a focused PatentsView assignee: 1 CPC subclasses with 50% of grants classified under A01K (Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2023. By volume, Megabass sits between Medrelief Inc. and Melodea Ltd..
Megabass, Inc shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Medrelief Inc.
6 patents
Medsapiens Co., Ltd.
6 patents
Medstreaming, Inc.
6 patents
Mega Slam Hoops, LLC
6 patents
Meijo Nano Carbon Co., Ltd.
6 patents
Meishan Crrc Fastening System Co., Ltd
6 patents
Melbourne Health
6 patents
Melodea Ltd.
6 patents
Megabass, Inc
6 patents
What this shows Megabass holds 6 patents at rank #41,554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,554 in granted patent volume.
Other assignees with the most granted patents in Megabass's primary technology class.
Megabass's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
16 3rd percentile higher than 3% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 50.0% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
| 2025partial year | 1 | 16.7% |
Top 1 of 1 technology areas
Overall rank by patents
#41,639
of 49,997 tracked assignees
15.8 out of 100
What to do with this data
Megabass, Inc's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.